Inovio Pharmaceuticals (INO) EPS (Basic) (2010 - 2026)
Inovio Pharmaceuticals (INO) posted EPS (Basic) of -$0.34 for Q1 2026, up 5.79% sequentially from -$0.36 in Q4 2025, and up 65.16% YoY from -$0.21 in Q1 2025.
Inovio Pharmaceuticals (INO) EPS (Basic) (2010 - 2026) Analysis & Trends
Inovio Pharmaceuticals has reported EPS (Basic) for 17 years, with the latest figure at -$0.34 in Q1 2026.
- Quarterly EPS (Basic) rose 65.16% year-over-year to -$0.34 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.22 (up 59.64% YoY) and the FY2025 annual result came in at -$9.87, up 41.31% from the prior year.
- EPS (Basic) advanced to -$0.34 in Q1 2026 per INO's latest filing, from -$0.36 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.34 in Q1 2026 and troughed at -$5.53 in Q2 2022.
- A 5-year average of -$1.61 and a median of -$1.22 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) sank 31.75% in 2022, then jumped 70.85% in 2023.
- Over 5 years, EPS (Basic) stood at -$2.74 in 2022, then soared by 58.83% to -$1.13 in 2023, then soared by 36.28% to -$0.72 in 2024, then jumped by 49.46% to -$0.36 in 2025, then rose by 5.79% to -$0.34 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.34, -$0.36, and -$0.4 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Inovio Pharmaceuticals | 97.94 Mn | 97.94 Mn | - | -0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.40 |
| Mar 31, 2026 | -0.34 |
| Dec 31, 2025 | -0.36 |
| Sep 30, 2025 | -0.40 |
| Jun 30, 2025 | -0.59 |
| Mar 31, 2025 | -0.98 |
| Dec 31, 2024 | -0.72 |
| Sep 30, 2024 | -0.93 |
| Jun 30, 2024 | -1.22 |
| Mar 31, 2024 | -1.38 |
| Dec 31, 2023 | -1.13 |
| Sep 30, 2023 | -1.52 |
| Jun 30, 2023 | -1.61 |
| Mar 31, 2023 | -1.89 |
| Dec 31, 2022 | -2.74 |
| Sep 30, 2022 | -1.82 |
| Jun 30, 2022 | -5.53 |
| Mar 31, 2022 | -4.22 |
| Dec 31, 2021 | -6.15 |
| Sep 30, 2021 | -3.43 |